Table 2.
Upper gastrointestinal cancers | |||||
Study |
Study location |
Cancer type |
Sample size |
Odds Ratios (OR), Relative Risk (RR), 95% Confidence Intervals (CI), P-values |
|
Cases | Controls | ||||
Kayamba, 201521 | Zambia | Oesophageal | 50 | 50 | OR= 3.6; 95% CI = 1.4 to 9.3; P = 0.004 |
Wang, 201322 | South Africa | Oesophageal (gene-environment interaction) |
565 | 1003 | OR= 1.75; 95% CI = 1.24 to 2.46; P = 0.001 |
Li, 201023 | South Africa | Oesophageal (gene-environment interaction) |
245 | 288 | OR = 12.1; 95% CI = 3.26 to 49 |
Dandara, 200624 | South Africa | Oesophageal | 63 | 20 | OR = 15.2; 95% CI = 8.15 to 28.2; P = 0.0001 |
Patel, 201325 | Kenya | Oesophageal | 159 | 159 | OR = 2.32; 95% CI = 1.41 to 3.84; P < 0.001 |
Mota, 201326 | Brazil | Oesophageal | 99 | 223 | OR = 4.42; 95% CI = 2.35 to 8.32; P < 0.001 |
Mlombe, 201527 | Malawi | Oesophageal | 96 | 180 | OR = 12.6; 95% CI = 4.2 to 37.7 |
Sapkota, 201328 | Multicentre | Oesophageal | 1110 | 186 | OR = 2.71; 95% CI = 1.21 to 6.10 |
Chirinos, 201231 | Peru | Gastric | 96 | 96 | OR = 5 |
Rafkin, 201532 | Honduras | Gastric | 814 | 1049 | OR = 3.54; 95% CI = 2.18 to 5.77 |
Other cancer types | |||||
Study |
Study location |
Cancer Type |
Sample size |
Odds Ratios (OR), Relative Risk (RR), 95% Confidence intervals (CI), P-values |
|
Cases | Controls | ||||
Gerhardsson de Verdier, 199238 |
Sweden | Colon Rectal | 21 | 27 | RR = 1.2; 95% CI = 0.6 to 2.2 RR = 1.9; 95% CI = 1.0 to 3.7 |
Raspanti, 201639 | Nepal | Lung | 606 | 606 | OR = 1.77; 95% CI = 1.00 to 3.14 |
Saikia, 201440 | India | Lung | 272 | 544 | OR = 3.6; 95% CI = 1.85 to 6.98; P < 0.001 |
Phukan, 201441 | India | Lung | 230 | 460 | OR = 1.5; 95% CI = 1.01 to 2.22; P = 0.044 |
Sloan, 201242 | USA | Lung | 277 | 251 | OR = 2.43; 95% CI = 1.26 to 4.67 P = 0.008 |
Hernández-Garduño, 200443 | Mexico | Lung | 113 | 273 | OR = 1.9; 95% CI = 1.1 to 3.5 |
Levin, 198844 | China | Lung | 738 | 760 | OR = 1.8; 95% CI = 1.3 to 2.5 |
Sierra-Torres, 200645 |
Colombia | Cervical | 91 | 92 | OR = 3.3; 95% CI = 0.5 to 22.5 |
Velema, 200246 | Honduras | Cervical | 45 | 241 | P = 0.022 |
Ferrera, 200047 | Honduras | Cervical | 99 | 198 | P = 0.0001 |
He, 201548 | China | Nasopharyngeal | 1845 | 2275 | OR = 1.95; 95% CI = 1.65 to 2.31 |
Pintos, 199849 | Brazil | Oral Pharyngeal Laryngeal |
373 217 194 |
1568 | OR = 2.73; 95% CI = 1.8 to 4.2 OR = 3.82; 95% CI = 2.0 to 7.4 OR = 2.34; 95% CI = 1.2 to 4.7 |
Sapkota, 200850 | India | Hypopharyngeal | 799 | 1062 | OR = 1.62; 95% CI = 1.14 to 2.32 |
Greenop, 201551 | Australia | Childhood brain tumours | 306 | 950 | OR = 1.51; 95% CI = 1.05 to 2.15 |
While this review is focused on upper gastrointestinal cancers in Africa, studies from other geographical locations and reporting about other cancer types are included to illustrated similarities.